Associate Editor

Dr. Dreicer is Head of the Section of Medical Oncology, Associate Director of Clinical Research, and Deputy Director of the University of Virginia Comprehensive Cancer Center, Charlottesville. He received his medical degree and master of science from the University of Texas, Houston. He completed internal medicine residency training at Indiana University and a medical oncology fellowship at the University of Wisconsin. He is a Master of the American College of Physicians and a Fellow of the American Society of Clinical Oncology. Dr. Dreicer is an academic clinical investigator in the area of urologic oncology.
Astellas; Merck; Pfizer; LNC Pharma, UroGen Pharma
MacroGenics; Bristol Myers Squib; Exelixis; Regeneron
Current Urology Reports